Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11707532 Compositions and methods of treating muscle dystrophy

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Avidity Biosciences

0

Current Assignee

Avidity Biosciences

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

July 25, 2023

0

Patent Application Number

178183190

Date Filed

August 8, 2022

0

Patent Citations

US Patent 7528126 Pyrrolobenzodiazepines

0

US Patent 7612062 Pyrrolobenzodiazepines

0

US Patent 7659241 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease

0

US Patent 7691997 Functional and hyperfunctional siRNA

0

US Patent 7704924 Library of compounds comprising pyrrolobenzodiazepine moieties

0

US Patent 7709226 Method of humanizing antibodies by matching canonical structure types CDRs

0

US Patent 7750116 Antibody drug conjugate metabolites

0

US Patent 7833992 Conjugates and compositions for cellular delivery

0

...

Patent Primary Examiner

0

Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle dystrophy (DM1).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11707532 Compositions and methods of treating muscle dystrophy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool